These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3156740)

  • 1. Studies on 18F-labeled pyrimidines III. Biochemical investigation of 18F-labeled pyrimidines and comparison with 3H-deoxythymidine in tumor-bearing rats and mice.
    Ishiwata K; Ido T; Abe Y; Matsuzawa T; Murakami M
    Eur J Nucl Med; 1985; 10(1-2):39-44. PubMed ID: 3156740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses of 18F-labeled pyrimidines and their usefulness for tumor imaging.
    Ishiwata K; Ido T; Takahashi T; Monma M; Iwata R; Abe Y; Matsuzawa T; Tsurumi Y; Kameyama M
    Nucleic Acids Symp Ser; 1984; (15):25-8. PubMed ID: 6240636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on 18F-labeled pyrimidines. II. Metabolic investigation of 18F-5-fluorouracil, 18F-5-fluoro-2'-deoxyuridine and 18F-5-fluorouridine in rats.
    Ishiwata K; Ido T; Kawashima K; Murakami M; Takahashi T
    Eur J Nucl Med; 1984; 9(4):185-9. PubMed ID: 6232143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
    Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
    Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
    Ishiwata K; Takahashi T; Iwata R; Tomura M; Tada M; Itoh J; Kameyama M; Ido T
    Int J Rad Appl Instrum B; 1992 Aug; 19(6):611-8. PubMed ID: 1387872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, and 18F-5-fluorodeoxyuridine in animals.
    Abe Y; Fukuda H; Ishiwata K; Yoshioka S; Yamada K; Endo S; Kubota K; Sato T; Matsuzawa T; Takahashi T; Ido T
    Eur J Nucl Med; 1983; 8(6):258-61. PubMed ID: 6223818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
    Boothman DA; Briggle TV; Greer S
    Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fates of 2'-deoxy-5-[18F]fluorouridine in tumor-bearing mice and human plasma.
    Ishiwata K; Sato K; Kameyama M; Yoshimoto T; Ido T
    Int J Rad Appl Instrum B; 1991; 18(5):539-45. PubMed ID: 1833361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.
    Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ
    Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.
    Takimoto CH; Tan YY; Cadman EC; Armstrong RD
    Biochem Pharmacol; 1987 Oct; 36(19):3243-8. PubMed ID: 2444230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M; Hoshi A
    Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
    Eiseman JL; Brown-Proctor C; Kinahan PE; Collins JM; Anderson LW; Joseph E; Hamburger DR; Pan SS; Mathis CA; Egorin MJ; Klecker RW
    Clin Cancer Res; 2004 Oct; 10(19):6669-76. PubMed ID: 15475457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine in the adenocarcinoma 755 system by guanosine 5'-monophosphate.
    Iigo M; Yamaizumi Z; Nakajima Y; Nishimura S; Hoshi A
    Drugs Exp Clin Res; 1988; 14(4):257-63. PubMed ID: 2458897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FLT and 125I-IdUrd uptake increase in human tumour cell lines induced by the thymidylate synthase inhibitor FdUrd.
    Viertl D; Perillo-Adamer F; André PA; Ametamey SM; Ross TL; Kosinski M; Dupertuis YM; Bischof Delaloye A; Buchegger F
    Nuklearmedizin; 2012; 51(5):163-9. PubMed ID: 22576273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
    Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
    Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice.
    Houghton JA; Houghton PJ
    Cancer; 1980 Mar; 45(5 Suppl):1159-67. PubMed ID: 6444543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine.
    Woodman PW; Sarrif AM; Heidelberger C
    Cancer Res; 1980 Mar; 40(3):507-11. PubMed ID: 6451286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study.
    Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
    J Nucl Med; 1994 Jun; 35(6):1067-75. PubMed ID: 8195872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicities.
    Barberi-Heyob M; Weber B; Merlin JL; Dittrich C; de Bruijn EA; Luporsi E; Guillemin F
    Cancer Chemother Pharmacol; 1995; 37(1-2):110-6. PubMed ID: 7497579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.